Ipilimumab vs Semaglutide
Ipilimumab vs Semaglutide: Overview
This comparison examines the pharmacological differences between Ipilimumab and Semaglutide.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Semaglutide: GLP-1 receptor agonist with enhanced albumin binding for extended action.
Pharmacokinetics
Half-life: Ipilimumab — 14.7 days; Semaglutide — 7 days.
Chemical Properties
Type: Ipilimumab — Antibody; Semaglutide — Protein.